In the last trading session, 2.82 million shares of the Cogent Biosciences Inc (NASDAQ:COGT) were traded, and its beta was 1.77. Most recently the company’s share price was $8.99, and it changed around $0.09 or 1.01% from the last close, which brings the market valuation of the company to $915.87M. COGT currently trades at a discount to its 52-week high of $12.61, offering almost -40.27% off that amount. The share price’s 52-week low was $3.67, which indicates that the current value has risen by an impressive 59.18% since then. We note from Cogent Biosciences Inc’s average daily trading volume that its 10-day average is 1.71 million shares, with the 3-month average coming to 1.08 million.
Cogent Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.36. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 2 recommended COGT as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Cogent Biosciences Inc is expected to report earnings per share of -0.59 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cogent Biosciences Inc (NASDAQ:COGT) trade information
Instantly COGT has showed a green trend with a performance of 1.01% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 11.16 on recent trading dayincreased the stock’s daily price by 19.44%. The company’s shares are currently up 52.89% year-to-date, but still down -13.56% over the last five days. On the other hand, Cogent Biosciences Inc (NASDAQ:COGT) is -24.45% down in the 30-day period. We can see from the shorts that 8.43 million shares have been sold at a short interest cover period of 8.79 day(s).
The consensus price target as assigned by Wall Street analysts is $18.5, which translates to bulls needing to increase their stock price by 51.41% from its current value. Analyst projections state that COGT is forecast to be at a low of $15 and a high of $24.
Cogent Biosciences Inc (COGT) estimates and forecasts
Cogent Biosciences Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 14.67 percent over the past six months and at a 0.83% annual growth rate that is well below the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 7.08% in revenue this quarter, and will report a decrease of -0.81% in the next quarter.
Forecasts for the next quarter put sales growth at �.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.33%.
COGT Dividends
Cogent Biosciences Inc’s next quarterly earnings report is expected to be released in December.
COMMODORE CAPITAL LP, with 9.8126% or 9.74 million shares worth $82.09 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
